ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rapid Antigen Testing (RAT) for COVID-19 Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-12U10782
Home | Market Reports | Health| Medical Devices & Equipment
Global Rapid Antigen Testing RAT for COVID 19 Market Research Report 2022
BUY CHAPTERS

Global Rapid Antigen Testing (RAT) for COVID-19 Market Research Report 2025

Code: QYRE-Auto-12U10782
Report
February 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Quidel
Access Bio
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
Roche
BD
Orasure Technologies
Clip Health
Princeton BioMeditech Corporation
Rapigen
ORIENT GENE
Wondfo Biotech
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
LumiraDx
Ihealth (Andon Health)

Rapid Antigen Testing (RAT) for COVID-19 Market

The global market for Rapid Antigen Testing (RAT) for COVID-19 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rapid Antigen Testing (RAT) for COVID-19 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Rapid Antigen Testing (RAT) for COVID-19 include Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, AESKU.GROUP, ROCHE, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rapid Antigen Testing (RAT) for COVID-19, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rapid Antigen Testing (RAT) for COVID-19.
The Rapid Antigen Testing (RAT) for COVID-19 market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rapid Antigen Testing (RAT) for COVID-19 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rapid Antigen Testing (RAT) for COVID-19 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Rapid Antigen Testing (RAT) for COVID-19 Market Report

Report Metric Details
Report Name Rapid Antigen Testing (RAT) for COVID-19 Market
Segment by Type
  • Fluorescence Immunochromatography
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Others
Segment by Application
  • Hospitals
  • Community Testing
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, AESKU.GROUP, ROCHE, BD, OraSure Technologies, Clip Health, LumiraDx, Princeton BioMeditech Corporation, RapiGEN Inc., Orient Gene, Wondfo Biotech, Ihealth (Andon Health), Wantai BioPharm, Biotest Biotech, Shenzhen YHLO Biotech, Vazyme Biotech, EasyDiagnosis Biomedicine, Beijing Hotgen Biotech, Assure Tech, Hangzhou AllTest Biotech, ACON Biotech, BGI Genomics, Lepu Medical Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Rapid Antigen Testing (RAT) for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Rapid Antigen Testing (RAT) for COVID-19 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Rapid Antigen Testing (RAT) for COVID-19 Market report?

Ans: The main players in the Rapid Antigen Testing (RAT) for COVID-19 Market are Abbott, Quidel, ACCESS BIO, CTK Biotech, SD Biosensor, Ellume, InBios, Celltrion, AESKU.GROUP, ROCHE, BD, OraSure Technologies, Clip Health, LumiraDx, Princeton BioMeditech Corporation, RapiGEN Inc., Orient Gene, Wondfo Biotech, Ihealth (Andon Health), Wantai BioPharm, Biotest Biotech, Shenzhen YHLO Biotech, Vazyme Biotech, EasyDiagnosis Biomedicine, Beijing Hotgen Biotech, Assure Tech, Hangzhou AllTest Biotech, ACON Biotech, BGI Genomics, Lepu Medical Technology

What are the Application segmentation covered in the Rapid Antigen Testing (RAT) for COVID-19 Market report?

Ans: The Applications covered in the Rapid Antigen Testing (RAT) for COVID-19 Market report are Hospitals, Community Testing, Other

What are the Type segmentation covered in the Rapid Antigen Testing (RAT) for COVID-19 Market report?

Ans: The Types covered in the Rapid Antigen Testing (RAT) for COVID-19 Market report are Fluorescence Immunochromatography, Colloidal Gold Immunochromatography, Latex Immunochromatography, Others

1 Rapid Antigen Testing (RAT) for COVID-19 Market Overview
1.1 Product Definition
1.2 Rapid Antigen Testing (RAT) for COVID-19 by Type
1.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2024 VS 2031)
1.2.2 Fluorescence Immunochromatography
1.2.3 Colloidal Gold Immunochromatography
1.2.4 Latex Immunochromatography
1.2.5 Others
1.3 Rapid Antigen Testing (RAT) for COVID-19 by Application
1.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Community Testing
1.3.4 Other
1.4 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size Estimates and Forecasts
1.4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue 2020-2031
1.4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales 2020-2031
1.4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Rapid Antigen Testing (RAT) for COVID-19 Market Competition by Manufacturers
2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2020-2025)
2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Rapid Antigen Testing (RAT) for COVID-19, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Product Type & Application
2.7 Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Date of Enter into This Industry
2.8 Global Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation and Trends
2.8.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players Market Share by Revenue
2.8.3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Rapid Antigen Testing (RAT) for COVID-19 Market Scenario by Region
3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2020-2031
3.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2020-2025
3.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region: 2026-2031
3.3 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2020-2031
3.3.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2020-2025
3.3.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2026-2031
3.4 North America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.4.1 North America Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2031)
3.4.3 North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.5.1 Europe Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2031)
3.5.3 Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Region
3.6.1 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2020-2031)
3.6.3 Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.7.1 Latin America Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2031)
3.7.3 Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Facts & Figures by Country
3.8.1 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2031)
3.8.3 Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2020-2031)
4.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2020-2025)
4.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Type (2026-2031)
4.1.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2020-2031)
4.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2020-2031)
4.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2020-2025)
4.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Type (2026-2031)
4.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2020-2031)
4.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Type (2020-2031)
5 Segment by Application
5.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2020-2031)
5.1.1 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2020-2025)
5.1.2 Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Application (2026-2031)
5.1.3 Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2020-2031)
5.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2020-2031)
5.2.1 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2020-2025)
5.2.2 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Application (2026-2031)
5.2.3 Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2020-2031)
5.3 Global Rapid Antigen Testing (RAT) for COVID-19 Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Quidel
6.2.1 Quidel Company Information
6.2.2 Quidel Description and Business Overview
6.2.3 Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Quidel Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.2.5 Quidel Recent Developments/Updates
6.3 ACCESS BIO
6.3.1 ACCESS BIO Company Information
6.3.2 ACCESS BIO Description and Business Overview
6.3.3 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.3.4 ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.3.5 ACCESS BIO Recent Developments/Updates
6.4 CTK Biotech
6.4.1 CTK Biotech Company Information
6.4.2 CTK Biotech Description and Business Overview
6.4.3 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.4.5 CTK Biotech Recent Developments/Updates
6.5 SD Biosensor
6.5.1 SD Biosensor Company Information
6.5.2 SD Biosensor Description and Business Overview
6.5.3 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.5.4 SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.5.5 SD Biosensor Recent Developments/Updates
6.6 Ellume
6.6.1 Ellume Company Information
6.6.2 Ellume Description and Business Overview
6.6.3 Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ellume Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.6.5 Ellume Recent Developments/Updates
6.7 InBios
6.7.1 InBios Company Information
6.7.2 InBios Description and Business Overview
6.7.3 InBios Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.7.4 InBios Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.7.5 InBios Recent Developments/Updates
6.8 Celltrion
6.8.1 Celltrion Company Information
6.8.2 Celltrion Description and Business Overview
6.8.3 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.8.5 Celltrion Recent Developments/Updates
6.9 AESKU.GROUP
6.9.1 AESKU.GROUP Company Information
6.9.2 AESKU.GROUP Description and Business Overview
6.9.3 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.9.4 AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.9.5 AESKU.GROUP Recent Developments/Updates
6.10 ROCHE
6.10.1 ROCHE Company Information
6.10.2 ROCHE Description and Business Overview
6.10.3 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.10.4 ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.10.5 ROCHE Recent Developments/Updates
6.11 BD
6.11.1 BD Company Information
6.11.2 BD Description and Business Overview
6.11.3 BD Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BD Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.11.5 BD Recent Developments/Updates
6.12 OraSure Technologies
6.12.1 OraSure Technologies Company Information
6.12.2 OraSure Technologies Description and Business Overview
6.12.3 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.12.4 OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.12.5 OraSure Technologies Recent Developments/Updates
6.13 Clip Health
6.13.1 Clip Health Company Information
6.13.2 Clip Health Description and Business Overview
6.13.3 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.13.5 Clip Health Recent Developments/Updates
6.14 LumiraDx
6.14.1 LumiraDx Company Information
6.14.2 LumiraDx Description and Business Overview
6.14.3 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.14.4 LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.14.5 LumiraDx Recent Developments/Updates
6.15 Princeton BioMeditech Corporation
6.15.1 Princeton BioMeditech Corporation Company Information
6.15.2 Princeton BioMeditech Corporation Description and Business Overview
6.15.3 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.15.5 Princeton BioMeditech Corporation Recent Developments/Updates
6.16 RapiGEN Inc.
6.16.1 RapiGEN Inc. Company Information
6.16.2 RapiGEN Inc. Description and Business Overview
6.16.3 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.16.4 RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.16.5 RapiGEN Inc. Recent Developments/Updates
6.17 Orient Gene
6.17.1 Orient Gene Company Information
6.17.2 Orient Gene Description and Business Overview
6.17.3 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.17.5 Orient Gene Recent Developments/Updates
6.18 Wondfo Biotech
6.18.1 Wondfo Biotech Company Information
6.18.2 Wondfo Biotech Description and Business Overview
6.18.3 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.18.5 Wondfo Biotech Recent Developments/Updates
6.19 Ihealth (Andon Health)
6.19.1 Ihealth (Andon Health) Company Information
6.19.2 Ihealth (Andon Health) Description and Business Overview
6.19.3 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.19.5 Ihealth (Andon Health) Recent Developments/Updates
6.20 Wantai BioPharm
6.20.1 Wantai BioPharm Company Information
6.20.2 Wantai BioPharm Description and Business Overview
6.20.3 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.20.5 Wantai BioPharm Recent Developments/Updates
6.21 Biotest Biotech
6.21.1 Biotest Biotech Company Information
6.21.2 Biotest Biotech Description and Business Overview
6.21.3 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.21.5 Biotest Biotech Recent Developments/Updates
6.22 Shenzhen YHLO Biotech
6.22.1 Shenzhen YHLO Biotech Company Information
6.22.2 Shenzhen YHLO Biotech Description and Business Overview
6.22.3 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.22.5 Shenzhen YHLO Biotech Recent Developments/Updates
6.23 Vazyme Biotech
6.23.1 Vazyme Biotech Company Information
6.23.2 Vazyme Biotech Description and Business Overview
6.23.3 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.23.5 Vazyme Biotech Recent Developments/Updates
6.24 EasyDiagnosis Biomedicine
6.24.1 EasyDiagnosis Biomedicine Company Information
6.24.2 EasyDiagnosis Biomedicine Description and Business Overview
6.24.3 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.24.4 EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.24.5 EasyDiagnosis Biomedicine Recent Developments/Updates
6.25 Beijing Hotgen Biotech
6.25.1 Beijing Hotgen Biotech Company Information
6.25.2 Beijing Hotgen Biotech Description and Business Overview
6.25.3 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.25.4 Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.25.5 Beijing Hotgen Biotech Recent Developments/Updates
6.26 Assure Tech
6.26.1 Assure Tech Company Information
6.26.2 Assure Tech Description and Business Overview
6.26.3 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.26.4 Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.26.5 Assure Tech Recent Developments/Updates
6.27 Hangzhou AllTest Biotech
6.27.1 Hangzhou AllTest Biotech Company Information
6.27.2 Hangzhou AllTest Biotech Description and Business Overview
6.27.3 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.27.4 Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.27.5 Hangzhou AllTest Biotech Recent Developments/Updates
6.28 ACON Biotech
6.28.1 ACON Biotech Company Information
6.28.2 ACON Biotech Description and Business Overview
6.28.3 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.28.4 ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.28.5 ACON Biotech Recent Developments/Updates
6.29 BGI Genomics
6.29.1 BGI Genomics Company Information
6.29.2 BGI Genomics Description and Business Overview
6.29.3 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.29.4 BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.29.5 BGI Genomics Recent Developments/Updates
6.30 Lepu Medical Technology
6.30.1 Lepu Medical Technology Company Information
6.30.2 Lepu Medical Technology Description and Business Overview
6.30.3 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales, Revenue and Gross Margin (2020-2025)
6.30.4 Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product Portfolio
6.30.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Chain Analysis
7.2 Rapid Antigen Testing (RAT) for COVID-19 Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rapid Antigen Testing (RAT) for COVID-19 Production Mode & Process Analysis
7.4 Rapid Antigen Testing (RAT) for COVID-19 Sales and Marketing
7.4.1 Rapid Antigen Testing (RAT) for COVID-19 Sales Channels
7.4.2 Rapid Antigen Testing (RAT) for COVID-19 Distributors
7.5 Rapid Antigen Testing (RAT) for COVID-19 Customer Analysis
8 Rapid Antigen Testing (RAT) for COVID-19 Market Dynamics
8.1 Rapid Antigen Testing (RAT) for COVID-19 Industry Trends
8.2 Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
8.3 Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
8.4 Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Quidel
Access Bio
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
Roche
BD
Orasure Technologies
Clip Health
Princeton BioMeditech Corporation
Rapigen
ORIENT GENE
Wondfo Biotech
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
LumiraDx
Ihealth (Andon Health)
List of Tables
 Table 1. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Rapid Antigen Testing (RAT) for COVID-19 Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Rapid Antigen Testing (RAT) for COVID-19, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Product Type & Application
 Table 12. Global Key Manufacturers of Rapid Antigen Testing (RAT) for COVID-19, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Rapid Antigen Testing (RAT) for COVID-19 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Antigen Testing (RAT) for COVID-19 as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2020-2025) & (K Units)
 Table 18. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2020-2025)
 Table 19. Global Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2026-2031) & (K Units)
 Table 20. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2026-2031)
 Table 21. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2020-2025)
 Table 23. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2026-2031)
 Table 25. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2025) & (K Units)
 Table 27. North America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2026-2031) & (K Units)
 Table 28. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Type (2020-2025)
 Table 51. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Type (2026-2031)
 Table 52. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2020-2025)
 Table 53. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Type (2026-2031)
 Table 54. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2020-2025)
 Table 57. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Type (2026-2031)
 Table 58. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Application (2020-2025)
 Table 61. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units) by Application (2026-2031)
 Table 62. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2020-2025)
 Table 63. Global Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Application (2026-2031)
 Table 64. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2020-2025)
 Table 67. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Application (2026-2031)
 Table 68. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Quidel Company Information
 Table 76. Quidel Description and Business Overview
 Table 77. Quidel Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Quidel Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 79. Quidel Recent Developments/Updates
 Table 80. ACCESS BIO Company Information
 Table 81. ACCESS BIO Description and Business Overview
 Table 82. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. ACCESS BIO Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 84. ACCESS BIO Recent Developments/Updates
 Table 85. CTK Biotech Company Information
 Table 86. CTK Biotech Description and Business Overview
 Table 87. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CTK Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 89. CTK Biotech Recent Developments/Updates
 Table 90. SD Biosensor Company Information
 Table 91. SD Biosensor Description and Business Overview
 Table 92. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. SD Biosensor Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 94. SD Biosensor Recent Developments/Updates
 Table 95. Ellume Company Information
 Table 96. Ellume Description and Business Overview
 Table 97. Ellume Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ellume Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 99. Ellume Recent Developments/Updates
 Table 100. InBios Company Information
 Table 101. InBios Description and Business Overview
 Table 102. InBios Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. InBios Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 104. InBios Recent Developments/Updates
 Table 105. Celltrion Company Information
 Table 106. Celltrion Description and Business Overview
 Table 107. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Celltrion Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 109. Celltrion Recent Developments/Updates
 Table 110. AESKU.GROUP Company Information
 Table 111. AESKU.GROUP Description and Business Overview
 Table 112. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. AESKU.GROUP Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 114. AESKU.GROUP Recent Developments/Updates
 Table 115. ROCHE Company Information
 Table 116. ROCHE Description and Business Overview
 Table 117. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. ROCHE Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 119. ROCHE Recent Developments/Updates
 Table 120. BD Company Information
 Table 121. BD Description and Business Overview
 Table 122. BD Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BD Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 124. BD Recent Developments/Updates
 Table 125. OraSure Technologies Company Information
 Table 126. OraSure Technologies Description and Business Overview
 Table 127. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. OraSure Technologies Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 129. OraSure Technologies Recent Developments/Updates
 Table 130. Clip Health Company Information
 Table 131. Clip Health Description and Business Overview
 Table 132. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Clip Health Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 134. Clip Health Recent Developments/Updates
 Table 135. LumiraDx Company Information
 Table 136. LumiraDx Description and Business Overview
 Table 137. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. LumiraDx Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 139. LumiraDx Recent Developments/Updates
 Table 140. Princeton BioMeditech Corporation Company Information
 Table 141. Princeton BioMeditech Corporation Description and Business Overview
 Table 142. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Princeton BioMeditech Corporation Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 144. Princeton BioMeditech Corporation Recent Developments/Updates
 Table 145. RapiGEN Inc. Company Information
 Table 146. RapiGEN Inc. Description and Business Overview
 Table 147. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. RapiGEN Inc. Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 149. RapiGEN Inc. Recent Developments/Updates
 Table 150. Orient Gene Company Information
 Table 151. Orient Gene Description and Business Overview
 Table 152. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Orient Gene Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 154. Orient Gene Recent Developments/Updates
 Table 155. Wondfo Biotech Company Information
 Table 156. Wondfo Biotech Description and Business Overview
 Table 157. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Wondfo Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 159. Wondfo Biotech Recent Developments/Updates
 Table 160. Ihealth (Andon Health) Company Information
 Table 161. Ihealth (Andon Health) Description and Business Overview
 Table 162. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Ihealth (Andon Health) Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 164. Ihealth (Andon Health) Recent Developments/Updates
 Table 165. Wantai BioPharm Company Information
 Table 166. Wantai BioPharm Description and Business Overview
 Table 167. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Wantai BioPharm Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 169. Wantai BioPharm Recent Developments/Updates
 Table 170. Biotest Biotech Company Information
 Table 171. Biotest Biotech Description and Business Overview
 Table 172. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Biotest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 174. Biotest Biotech Recent Developments/Updates
 Table 175. Shenzhen YHLO Biotech Company Information
 Table 176. Shenzhen YHLO Biotech Description and Business Overview
 Table 177. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Shenzhen YHLO Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 179. Shenzhen YHLO Biotech Recent Developments/Updates
 Table 180. Vazyme Biotech Company Information
 Table 181. Vazyme Biotech Description and Business Overview
 Table 182. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Vazyme Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 184. Vazyme Biotech Recent Developments/Updates
 Table 185. EasyDiagnosis Biomedicine Company Information
 Table 186. EasyDiagnosis Biomedicine Description and Business Overview
 Table 187. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. EasyDiagnosis Biomedicine Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 189. EasyDiagnosis Biomedicine Recent Developments/Updates
 Table 190. Beijing Hotgen Biotech Company Information
 Table 191. Beijing Hotgen Biotech Description and Business Overview
 Table 192. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. Beijing Hotgen Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 194. Beijing Hotgen Biotech Recent Developments/Updates
 Table 195. Assure Tech Company Information
 Table 196. Assure Tech Description and Business Overview
 Table 197. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 198. Assure Tech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 199. Assure Tech Recent Developments/Updates
 Table 200. Hangzhou AllTest Biotech Company Information
 Table 201. Hangzhou AllTest Biotech Description and Business Overview
 Table 202. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 203. Hangzhou AllTest Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 204. Hangzhou AllTest Biotech Recent Developments/Updates
 Table 205. ACON Biotech Company Information
 Table 206. ACON Biotech Description and Business Overview
 Table 207. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 208. ACON Biotech Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 209. ACON Biotech Recent Developments/Updates
 Table 210. BGI Genomics Company Information
 Table 211. BGI Genomics Description and Business Overview
 Table 212. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 213. BGI Genomics Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 214. BGI Genomics Recent Developments/Updates
 Table 215. Lepu Medical Technology Company Information
 Table 216. Lepu Medical Technology Description and Business Overview
 Table 217. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 218. Lepu Medical Technology Rapid Antigen Testing (RAT) for COVID-19 Product
 Table 219. Lepu Medical Technology Recent Developments/Updates
 Table 220. Key Raw Materials Lists
 Table 221. Raw Materials Key Suppliers Lists
 Table 222. Rapid Antigen Testing (RAT) for COVID-19 Distributors List
 Table 223. Rapid Antigen Testing (RAT) for COVID-19 Customers List
 Table 224. Rapid Antigen Testing (RAT) for COVID-19 Market Trends
 Table 225. Rapid Antigen Testing (RAT) for COVID-19 Market Drivers
 Table 226. Rapid Antigen Testing (RAT) for COVID-19 Market Challenges
 Table 227. Rapid Antigen Testing (RAT) for COVID-19 Market Restraints
 Table 228. Research Programs/Design for This Report
 Table 229. Key Data Information from Secondary Sources
 Table 230. Key Data Information from Primary Sources
 Table 231. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Rapid Antigen Testing (RAT) for COVID-19
 Figure 2. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Type: 2024 & 2031
 Figure 4. Fluorescence Immunochromatography Product Picture
 Figure 5. Colloidal Gold Immunochromatography Product Picture
 Figure 6. Latex Immunochromatography Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Rapid Antigen Testing (RAT) for COVID-19 Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rapid Antigen Testing (RAT) for COVID-19 Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Community Testing
 Figure 12. Other
 Figure 13. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Rapid Antigen Testing (RAT) for COVID-19 Sales (2020-2031) & (K Units)
 Figure 16. Global Rapid Antigen Testing (RAT) for COVID-19 Average Price (US$/Unit) & (2020-2031)
 Figure 17. Rapid Antigen Testing (RAT) for COVID-19 Report Years Considered
 Figure 18. Rapid Antigen Testing (RAT) for COVID-19 Sales Share by Manufacturers in 2024
 Figure 19. Global Rapid Antigen Testing (RAT) for COVID-19 Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Rapid Antigen Testing (RAT) for COVID-19 Players: Market Share by Revenue in Rapid Antigen Testing (RAT) for COVID-19 in 2024
 Figure 21. Rapid Antigen Testing (RAT) for COVID-19 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Rapid Antigen Testing (RAT) for COVID-19 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2020-2031)
 Figure 24. North America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2020-2031)
 Figure 28. Europe Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Region (2020-2031)
 Figure 36. China Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Rapid Antigen Testing (RAT) for COVID-19 Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Rapid Antigen Testing (RAT) for COVID-19 Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Type (2020-2031)
 Figure 58. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Rapid Antigen Testing (RAT) for COVID-19 by Application (2020-2031)
 Figure 61. Global Rapid Antigen Testing (RAT) for COVID-19 Price (US$/Unit) by Application (2020-2031)
 Figure 62. Rapid Antigen Testing (RAT) for COVID-19 Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Covid 19 Rapid Antigen Market Research Report 2024
Global Rapid Covid 19 Antigen Test Kit Market Research Report 2025
Global Antigen COVID 19 Testing Service Market Research Report 2024
Global COVID 19 Antigen Detection Kit Market Research Report 2025
Global COVID 19 Antigen Testing Devices Market Research Report 2025
Global COVID 19 Antigen Detection Reagent Market Research Report 2025
Global COVID 19 Antigen Self Test Market Research Report 2024
Global COVID 19 Antibody Rapid Test Kits Market Research Report 2025
Global COVID 19 Antigen Self Test Kits Market Research Report 2025
Global COVID 19 Rapid Diagnostic Test Kit Market Research Report 2025
Global Covid 19 Antibody Test Market Research Report 2024
Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rapid COVID 19 Testing Devices Market Research Report 2024
Global Antigen Rapid Test Market Research Report 2025
Global COVID 19 IgM IgG Antibody Rapid Test Kits Market Research Report 2024
Global COVID 19 Antigen Kit Market Research Report 2024
Global COVID 19 Surface Testing Market Research Report 2025
Global COVID 19 Nasal Swab Test Market Research Report 2025
Global Rapid Antigen Testing Market Research Report 2024
Global COVID 19 Ag Self Test Kits Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions